Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Selective activation and expansion of regulatory T cells using lipid encapsulated mRNA encoding a long-acting IL-2 mutein
Seymour de Picciotto, Nicholas DeVita, Chiaowen Joyce Hsiao, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

IL-2 immunotherapy for targeting regulatory T cells in autoimmunity
Valentina Lykhopiy, Vanshika Malviya, Stéphanie Humblet‐Baron, et al.
Genes and Immunity (2023) Vol. 24, Iss. 5, pp. 248-262
Open Access | Times Cited: 30
Nanoparticle-based immunoengineering strategies for enhancing cancer immunotherapy
Bao-Toan Nguyen Dang, Taeg Kyu Kwon, Sooyeun Lee, et al.
Journal of Controlled Release (2023) Vol. 365, pp. 773-800
Closed Access | Times Cited: 24
Brain regulatory T cells
Adrian Liston, Emanuela Pasciuto, Denise Fitzgerald, et al.
Nature reviews. Immunology (2023) Vol. 24, Iss. 5, pp. 326-337
Closed Access | Times Cited: 23
The clinical impact of mRNA therapeutics in the treatment of cancers, infections, genetic disorders, and autoimmune diseases
Roham Deyhimfar, Mehrnaz Izady, Mohammadreza Shoghi, et al.
Heliyon (2024) Vol. 10, Iss. 5, pp. e26971-e26971
Open Access | Times Cited: 13
Progress and prospects of mRNA-based drugs in pre-clinical and clinical applications
Yingying Shi, Miaoyuan Shi, Yì Wáng, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 11
A humanized IL-2 mutein expands Tregs and prolongs transplant survival in preclinical models
Orhan Efe, Rodrigo Benedetti Gassen, Leela Morená, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 5
Open Access | Times Cited: 9
Emerging immunomodulatory strategies for cell therapeutics
Corrine Ying Xuan Chua, Allen Yujie Jiang, Tatiane Eufrásio-da-Silva, et al.
Trends in biotechnology (2022) Vol. 41, Iss. 3, pp. 358-373
Open Access | Times Cited: 29
Biomaterial-enhanced treg cell immunotherapy: A promising approach for transplant medicine and autoimmune disease treatment
Kazem Mashayekhi, Khashayarsha Khazaie, William A. Faubion, et al.
Bioactive Materials (2024) Vol. 37, pp. 269-298
Open Access | Times Cited: 5
Harnessing the biology of regulatory T cells to treat disease
Christine M. Wardell, Dominic A. Boardman, Megan K. Levings
Nature Reviews Drug Discovery (2024)
Closed Access | Times Cited: 5
Immune responses of different COVID-19 vaccination strategies by analyzing single-cell RNA sequencing data from multiple tissues using machine learning methods
Hao Li, Qinglan Ma, Jingxin Ren, et al.
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 11
Differences and Similarities of the Intravenously Administered Lipid Nanoparticles in Three Clinical Trials: Potential Linkage between Lipid Nanoparticles and Extracellular Vesicles
Yuta Suzuki, Yuri Katsurada, Kenji Hyodo
Molecular Pharmaceutics (2023) Vol. 20, Iss. 10, pp. 4883-4892
Closed Access | Times Cited: 11
An Updated Review of Interleukin-2 Therapy in Cancer and Autoimmune Diseases
Hale Radi, Elaheh Ferdosi-Shahandashti, Gholam Ali Kardar, et al.
Journal of Interferon & Cytokine Research (2024) Vol. 44, Iss. 4, pp. 143-157
Closed Access | Times Cited: 4
Photochemical radical decarboxylative disulfuration of α-keto acids and oxamic acids
Huangbin Sun, Xueting Bin, Qianfang Zhang, et al.
Chemical Communications (2024) Vol. 60, Iss. 62, pp. 8107-8110
Closed Access | Times Cited: 4
Synthetic mRNAs Containing Minimalistic Untranslated Regions Are Highly Functional In Vitro and In Vivo
Shahab Mamaghani, Rocco Roberto Penna, Julia Frei, et al.
Cells (2024) Vol. 13, Iss. 15, pp. 1242-1242
Open Access | Times Cited: 4
mRNA-delivery of IDO1 suppresses T cell-mediated autoimmunity
Laurie L. Kenney, Rebecca Suet-Yan Chiu, Michelle N Dutra, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 9, pp. 101717-101717
Open Access | Times Cited: 4
Real-world experience with low-dose IL-2 for children and young adults with refractory chronic graft-versus-host disease
Holly Wobma, Malika Kapadia, Haesook T. Kim, et al.
Blood Advances (2023) Vol. 7, Iss. 16, pp. 4647-4657
Open Access | Times Cited: 10
Directed disruption of IL2 aggregation and receptor binding sites produces designer biologics with enhanced specificity and improved production capacity
Amy Dashwood, Ntombizodwa Makuyana, Rob van der Kant, et al.
Computational and Structural Biotechnology Journal (2025) Vol. 27, pp. 1112-1123
Open Access
Cytokine-based immunotherapy in pancreatic cancer
Andrés Gordo-Ortiz, Inés Ortiz-de-Solórzano, Flor Navarro
International review of cell and molecular biology (2025)
Closed Access
Regulatory T cell-based therapies for type 1 diabetes: a narrative review
Tsvetelina Velikova, Georgi Vasilev, Diya Linkwinstar, et al.
Metabolism and Target Organ Damage (2025) Vol. 5, Iss. 2
Open Access
The role of the adaptive immune system in the initiation and persistence of multiple sclerosis
Ali Maisam Afzali, Thomas Korn
Seminars in Immunology (2025) Vol. 78, pp. 101947-101947
Open Access
Regulatory T cells in dominant immunologic tolerance
Peter Georgiev, Mehdi Benamar, SeongJun Han, et al.
Journal of Allergy and Clinical Immunology (2023) Vol. 153, Iss. 1, pp. 28-41
Closed Access | Times Cited: 8
Lipid-Encapsulated mRNAs Encoding Complex Fusion Proteins Potentiate Antitumor Immune Responses
Casey W. Shuptrine, Yuhui Chen, Jayalakshmi Miriyala, et al.
Cancer Research (2024) Vol. 84, Iss. 10, pp. 1550-1559
Open Access | Times Cited: 3
Association of serum interleukin-2 with severity and prognosis in hospitalized patients with community-acquired pneumonia: a prospective cohort study
Feng-Min Zhu, Juan Xu, Qi-Yuan He, et al.
Internal and Emergency Medicine (2024) Vol. 19, Iss. 7, pp. 1929-1939
Open Access | Times Cited: 3
Insights into the formulation of lipid nanoparticles for the optimization of mRNA therapeutics
Xiangyu Jiao, Xi He, Shugang Qin, et al.
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2024) Vol. 16, Iss. 5
Closed Access | Times Cited: 3
Molecular Engineering of Interleukin-2 for Enhanced Therapeutic Activity in Autoimmune Diseases
Luke M. Tomasovic, Kathy Liu, Derek VanDyke, et al.
BioDrugs (2023) Vol. 38, Iss. 2, pp. 227-248
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top